Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally.
Intuitive Surgical stock last closed at $479.20, down 0.43% from the previous day, and has decreased 0.61% in one year. It has overperformed other stocks in the Medical Instruments & Supplies industry by 0.64 percentage points. Intuitive Surgical stock is currently +12.75% from its 52-week low of $425.00, and -22.21% from its 52-week high of $616.00.
As of Aug 19, 2025, there are 358.48M ISRG shares outstanding. The market cap of ISRG is $171.78B. In the last 24 hours, 1.89M ISRG shares were traded.
You will need an online brokerage account in order to access the NASDAQ market and buy ISRG shares.
Based on our experience, eToro is the best stock brokerage. Here's why:
Get $10 towards your purchase of shares by creating an account with eToro now. This offer is only for US users.
Open eToro AccountNow that you've chosen the best brokerage, the next step is to fill out some personal information so you can invest in ISRG today.
Now that you have finished signing up on the best stock app for beginners, you need to deposit funds:
Check out the video below to see the process of depositing funds into your brokerage account.
After you have identified the best place to buy Intuitive Surgical stock, it's crucial to research their stock prior to investing, so you can comprehend the risk and opportunity.
WallStreetZen was designed to help average investors do better fundamental analysis quickly.
You can see all of the due diligence checks on ISRG's stock page.
Analysts use many financial metrics, analyses, models, and charts to gauge ISRG's intrinsic value.
Using relative valuations ratios:
You can access additional valuation analysis on ISRG's stock here.
Out of 11 Wall Street analysts who give recommendations on ISRG, the consensus analyst rating on Intuitive Surgical is a Buy
It's important to note that analyst forecasts are not recommendations, nor are they investment advice.
Ryan Zimmerman, a top 12% analyst from BTIG maintains ISRG with a strong buy rating and raises their ISRG price target from $566.00 to $571.00, on Jul 23, 2025.
BTIG's Ryan Zimmerman raised their price target on Intuitive Surgical (NASDAQ: ISRG) by 0.9% from $566 to $571 on 2025/07/23. The analyst maintained their Strong Buy rating on the stock.
Intuitive Surgical reported its Q2 2025 earnings.\
Although placements fell short of forecast for the second consecutive quarter, system average selling prices were solid, along with new global market expansion and healthy treatment demand, Zimmerman told readers.
For Q2 2025, Intuitive Surgical reported:
Management did not provide EPS and revenue guidance in its press release.
CEO Dave Rosa commented: “We’re pleased with our solid performance this quarter, highlighted by continued customer adoption of our newer and existing platforms, including da Vinci 5.
“We are committed to advancing care, and helping our customers provide better patient outcomes, better patient and care team experiences, broadening access to care, and decreasing the total cost of care.”
Vijay Kumar, a bottom 3% analyst from Evercore ISI Group maintains ISRG with a hold rating and raises their ISRG price target from $470.00 to $550.00, on Jul 8, 2025.
Imron Zafar, a bottom 49% analyst from Deutsche Bank downgrades ISRG to a strong sell rating and lowers their ISRG price target from $515.00 to $440.00, on Jun 9, 2025.
Joanne Wuensch, a top 6% analyst from Citigroup maintains ISRG with a strong buy rating and raises their ISRG price target from $590.00 to $650.00, on May 22, 2025.
Matt Miksic, a bottom 5% analyst from Barclays maintains ISRG with a strong buy rating and lowers their ISRG price target from $684.00 to $635.00, on Apr 24, 2025.
You can dig deeper into what analysts are forecasting on the Intuitive Surgical stock forecast page.
Last year, ISRG earnings were $2.61B. During the past five year, ISRG's earnings have grown by 17.51% per year. This was slower than the Medical Instruments & Supplies industry average of 17.62%.
Last year, ISRG revenue was $9.15B. In the last 5 year, ISRG's revenue has gone up by 15.98% per year. This was faster than the Medical Instruments & Supplies industry average of 12.11%.
Learn more about ISRG's earnings and revenue performance here.
In the last 12 months, insiders at ISRG have sold more shares than they have bought.
Gary S. Guthart, Executive Chair of the Board o of ISRG, was the latest ISRG insider to buy. They bought $469,333.57 worth of ISRG stock on Jul 28, 2025.
Get more info about who owns ISRG stock here.
No, Intuitive Surgical doesn't provide an income stream by paying out dividends.
One of the primary reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other community members have to say.
You have two main options:
Press the Open button and eToro will execute the order.
If you require more help with investing in stocks on eToro, click the helpful video below:
Now that you own some ISRG shares, you'll want to keep up with your new company.
Start a watchlist to track your ISRG stock.
To reiterate, here are the 6 steps to buy stock in Intuitive Surgical:
If you need a brokerage account, eToro is our recommended venue.
Get Started with eToro TodayIf you would like to keep track of your new investment in Intuitive Surgical, hit the button below to create your watchlist.